Amexdrug Corporation
AXRX
Rank in Stocks
#34150
Amexdrug Corporation, founded in 1963 and headquartered in Commerce,... Amexdrug Corporation, founded in 1963 and headquartered in Commerce, California, operates as a pharmaceutical and cosmeceutical enterprise. Primarily, the company, via its subsidiaries, distributes pharmaceutical products. Beyond this core function, Amexdrug is also deeply involved in the entire lifecycle of pharmaceutical drugs, cosmetics, and medical devices, from their research and development phases through manufacturing and ultimate sale. The company's operations are divided into two main divisions: Distribution and Health and Beauty Products. Its extensive distribution network encompasses a wide range of items, including prescription and over-the-counter medications, various non-drug products, and health and beauty essentials. Amexdrug also provides services in private manufacturing and labeling. Specific product lines manufactured and sold by the company, often under its Sponix brand, include facial and body creams, arthritic pain relief treatments, and hair and nail care products. These goods are supplied to a diverse clientele such as pharmacies, beauty salons, beauty supply outlets, and other retail establishments. Within the state of California, Amexdrug's distribution channels primarily target independent pharmacies, extending secondarily to smaller pharmacy chains, alternative care facilities, and various wholesalers and retailers. The company adopted the name Amexdrug Corporation in April 2000, changing from its previous identity as Harlyn Products, Inc., to reflect its strategic focus on pharmaceutical sales.
Share Price
$0.0002
Last synced: 2026-11-10
Market Cap
$33.88K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Amexdrug Corporation (AXRX)
Category
Healthcare
EPS for Amexdrug Corporation (AXRX)
EPS as of March 2026 TTM: $0.00
According to Amexdrug Corporation's latest financial reports, its current EPS (TTM) is $0.00. At the end of 2025 the company had an EPS of 0.00, equal to its 2024 EPS of 0.00.
EPS history for Amexdrug Corporation from 2015 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | 0.00 | 100.00% |
| 2025 | 0.00 | 100.00% |
| 2024 | 0.00 | -50.00% |
| 2023 | 0.00 | -99.54% |
| 2021 | $0.04 | 3,550.00% |
| 2020 | 0.00 | -7.69% |
| 2019 | 0.00 | 8.33% |
| 2018 | 0.00 | 71.43% |
| 2017 | 0.00 | 75.00% |
| 2016 | 0.00 | -33.33% |
| 2015 | 0.00 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $6.03 | 1,507,375.00% |
DE
|
|
| $6.01 | 1,501,850.00% |
DE
|
|
| $1.53 | 383,125.00% |
JP
|
|
| $3.66 | 914,900.00% |
CH
|
|
| $0.45 | 112,400.00% |
IL
|
Questions about Amexdrug Corporation's earnings per share (EPS)
What is Amexdrug Corporation's earnings per share (EPS)?
Amexdrug Corporation's earnings per share (EPS) over the last twelve months is $0.00, as of Mar 2026.
What was Amexdrug Corporation's earnings per share (EPS) in 2025?
In 2025, Amexdrug Corporation's earnings per share (EPS) was 0.00, compared with 0.00 in 2024.
How has Amexdrug Corporation's earnings per share (EPS) changed since 2020?
From 2020 to 2025, Amexdrug Corporation's earnings per share (EPS) was highest in 2021 ($0.04) and lowest in 2025 (0.00).
How does Amexdrug Corporation's earnings per share (EPS) compare with similar companies?
Amexdrug Corporation's earnings per share (EPS) ($0.00) is lower than that of all 5 similar companies listed above. The highest among them is MERCK Kommanditgesellschaft auf Aktien, with $6.03.